CHEMED CORP
CHEMED CORP
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 17 | 75 | 130 | 250 | 174 | 178 | 238 | 223 | 313 | 264 | 173 | 160 | |||||
Accounts Receivable Net Current | 215 | 183 | 216 | 185 | 286 | 171 | 196 | 185 | 177 | 182 | 168 | 120 | |||||
Inventory Net | 7 | 8 | 8 | 9 | 8 | 8 | 10 | 11 | 11 | 12 | 13 | 12 | |||||
Prepaid Taxes | 8 | 11 | 7 | 14 | 4 | 11 | 14 | 17 | 10 | 13 | 11 | 17 | |||||
Other Prepaid Expense Current | 27 | 27 | 35 | 33 | 30 | 26 | 31 | 29 | 28 | 30 | 30 | 29 | |||||
Assets Current | 274 | 303 | 395 | 491 | 502 | 395 | 490 | 465 | 540 | 501 | 395 | 337 | |||||
Deferred Compensation Plan Assets | 144 | 140 | 136 | 130 | 128 | 131 | 127 | 121 | 118 | 106 | 104 | 100 | |||||
Property Plant And Equipment Net | 208 | 206 | 204 | 202 | 200 | 201 | 201 | 202 | 203 | 204 | 205 | 208 | |||||
Operating Lease Right Of Use Asset | 134 | 131 | 128 | 132 | 131 | 127 | 134 | 132 | 132 | 126 | 123 | 127 | |||||
Intangible Assets Net Excluding Goodwill | 80 | 83 | 85 | 87 | 90 | 92 | 95 | 97 | 88 | 90 | 93 | 95 | |||||
Goodwill | 688 | 667 | 667 | 667 | 667 | 667 | 667 | 662 | 592 | 585 | 585 | 582 | |||||
Other Assets Noncurrent | 9 | 9 | 8 | 8 | 8 | 56 | 56 | 56 | 56 | 56 | 57 | 57 | |||||
Assets | 1,536 | 1,538 | 1,624 | 1,718 | 1,727 | 1,669 | 1,769 | 1,735 | 1,728 | 1,668 | 1,562 | 1,505 | |||||
Liabilities | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 66 | 64 | 48 | 51 | 48 | 44 | 45 | 43 | 56 | 64 | 57 | 41 | |||||
Accrued Insurance Current | 65 | 62 | 66 | 67 | 66 | 57 | 60 | 60 | 62 | 59 | 61 | 57 | |||||
Accrued Income Taxes Current | 26 | 3 | 1 | - | 38 | 8 | 3 | - | 27 | 7 | 5 | - | |||||
Employee Related Liabilities Current | 63 | 58 | 80 | 55 | 60 | 92 | 73 | 78 | 50 | 88 | 75 | 74 | |||||
Litigation Reserve Current | - | - | - | - | - | - | - | - | 7 | 6 | 7 | 6 | |||||
Operating Lease Liability Current | 41 | 41 | 42 | 44 | 43 | 42 | 42 | 41 | 39 | 39 | 38 | 39 | |||||
Other Liabilities Current | 61 | 59 | 55 | 48 | 36 | 43 | 41 | 39 | 40 | 56 | 55 | 85 | |||||
Liabilities Current | 321 | 287 | 292 | 264 | 291 | 286 | 265 | 262 | 282 | 312 | 297 | 302 | |||||
Deferred Income Tax Liabilities Net | 15 | 19 | 10 | 13 | 12 | 26 | 28 | 28 | 25 | 30 | 30 | 37 | |||||
Deferred Compensation Liability Classified Noncurr… | 143 | 136 | 132 | 128 | 127 | 126 | 122 | 120 | 118 | 104 | 103 | 99 | |||||
Long Term Debt Noncurrent | 91 | - | - | - | - | - | - | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 104 | 103 | 99 | 102 | 102 | 99 | 105 | 105 | 107 | 101 | 99 | 102 | |||||
Other Liabilities Noncurrent | 14 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | |||||
Liabilities | 688 | 559 | 547 | 519 | 545 | 550 | 534 | 528 | 544 | 560 | 543 | 553 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 38 | 38 | 38 | 38 | 38 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | |||||
Additional Paid In Capital Common Stock | 1,604 | 1,592 | 1,581 | 1,576 | 1,538 | 1,484 | 1,463 | 1,416 | 1,399 | 1,341 | 1,254 | 1,240 | |||||
Retained Earnings Accumulated Deficit | 3,014 | 2,955 | 2,887 | 2,832 | 2,786 | 2,722 | 2,639 | 2,571 | 2,506 | 2,447 | 2,363 | 2,294 | |||||
Treasury Stock Value | -3,809 | -3,608 | -3,431 | -3,249 | -3,183 | -3,127 | -2,905 | -2,819 | -2,761 | -2,720 | -2,637 | -2,622 | |||||
Stockholders Equity | 848 | 979 | 1,077 | 1,198 | 1,182 | 1,119 | 1,236 | 1,207 | 1,183 | 1,108 | 1,019 | 952 | |||||
Liabilities And Stockholders Equity | 1,536 | 1,538 | 1,624 | 1,718 | 1,727 | 1,669 | 1,769 | 1,735 | 1,728 | 1,668 | 1,562 | 1,505 | |||||
Accumulated Depreciation Depletion And Amortizatio… | 398 | - | 392 | 395 | 393 | - | 376 | 374 | 365 | - | 348 | 342 | |||||
Finite Lived Intangible Assets Accumulated Amortiz… | 72 | - | 67 | 64 | 62 | - | 57 | 54 | 51 | - | 46 | 44 | |||||
Common Stock Shares Authorized | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | |||||
Common Stock Par Or Stated Value Per Share | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Common Stock Shares Issued | 38 | 38 | 38 | 38 | 38 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | |||||
Treasury Stock Common Shares | 24 | 24 | 23 | 23 | 23 | 23 | 22 | 22 | 22 | 22 | 22 | 22 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 4.34% | 3.74% | 21.28% | - | - | - | - | - | - | - | - | - |
| 2025 | 0.66% | -2.96% | -20.18% | 11.49% | 9.84% | 7.00% | 2.56% | 1.07% | 4.92% | -7.81% | -6.19% | 5.98% |
| 2024 | -1.97% | -4.17% | -4.08% | 5.01% | 4.73% | 7.49% | 7.48% | -1.51% | 4.43% | -1.11% | -3.18% | -3.49% |
| 2023 | - | - | - | -3.73% | -2.02% | -3.84% | 3.10% | 1.80% | 3.25% | 3.61% | -4.11% | -9.68% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.85 | 1.05 | 1.35 | 1.86 | 1.73 | 1.38 | 1.85 | 1.78 | 1.91 | 1.61 | 1.33 | 1.11 | |||||
| Quick Ratio | 0.83 | 1.03 | 1.33 | 1.83 | 1.70 | 1.35 | 1.81 | 1.73 | 1.88 | 1.57 | 1.29 | 1.08 | |||||
| Working Capital | -47.35M | 15.49M | 103.20M | 227.49M | 211.83M | 109.05M | 225.66M | 202.86M | 257.64M | 188.79M | 97.32M | 34.67M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.81 | 0.57 | 0.51 | 0.43 | 0.46 | 0.49 | 0.43 | 0.44 | 0.46 | 0.51 | 0.53 | 0.58 | |||||
| Interest Coverage TTM | 169.72 | 193.28 | 203.40 | 217.24 | 230.95 | 205.89 | 224.28 | 218.72 | 171.59 | 109.58 | 71.10 | 58.63 | |||||
| Debt Ratio | 0.45 | 0.36 | 0.34 | 0.30 | 0.32 | 0.33 | 0.30 | 0.30 | 0.31 | 0.34 | 0.35 | 0.37 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.56 | 1.58 | 1.49 | 1.45 | 1.44 | 1.46 | 1.43 | 1.44 | 1.45 | 1.46 | 1.52 | 1.55 | |||||
| Days Sales Outstanding TTM | 36.01 | 25.52 | 29.72 | 26.87 | 33.96 | 26.47 | 27.98 | 23.85 | 26.35 | 25.86 | 23.76 | 21.43 | |||||
| Receivables Turnover TTM | 10.13 | 14.30 | 12.28 | 13.58 | 10.75 | 13.79 | 13.04 | 15.30 | 13.85 | 14.11 | 15.36 | 17.03 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 18.98 | 18.34 | 19.35 | 19.75 | 20.91 | 19.89 | 19.89 | 19.73 | 18.48 | 17.93 | 16.09 | 14.88 | |||||
| Free Cash Flow Per Share TTM | 27.58 | 22.61 | 25.04 | 25.45 | 21.55 | 24.49 | 20.81 | 16.75 | 20.00 | 18.17 | 17.15 | 18.59 | |||||
| Dividend Per Share TTM | 2.38 | 2.20 | 2.13 | 2.02 | 1.94 | 1.80 | 1.71 | 1.60 | 1.58 | 1.56 | 1.53 | 1.51 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 32.38% | 32.54% | 32.88% | 33.65% | 34.82% | 35.14% | 35.66% | 35.96% | 35.47% | 35.28% | 34.53% | 34.10% | |||||
| Operating Profit Margin TTM | 12.91% | 13.37% | 13.89% | 14.69% | 15.63% | 15.07% | 15.31% | 15.36% | 14.83% | 15.04% | 13.95% | 13.92% | |||||
| Net Profit Margin TTM | 10.23% | 10.48% | 11.02% | 11.56% | 12.40% | 12.42% | 12.69% | 12.88% | 12.36% | 12.03% | 10.99% | 10.36% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 2.07% | 4.06% | 6.45% | 7.55% | 8.52% | 7.37% | 6.83% | 6.79% | 5.96% | 6.06% | 4.50% | 2.13% | |||||
| Net Income Growth (1Y) | -15.86% | -12.17% | -7.60% | -3.51% | 8.94% | 10.82% | 23.37% | 32.86% | 18.29% | 9.17% | -6.69% | -18.31% | |||||
| EPS Growth (1Y) | -10.03% | -8.35% | -3.55% | -0.17% | 12.66% | 11.01% | 23.78% | 32.51% | 17.08% | 8.29% | -7.85% | -18.99% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 19.86 | 23.16 | 23.02 | 24.34 | 28.96 | 26.17 | 29.69 | 26.98 | 33.92 | 31.96 | 31.68 | 35.59 | |||||
| P/B TTM | 6.08 | 6.27 | 5.96 | 5.90 | 7.57 | 7.06 | 7.25 | 6.72 | 8.12 | 7.86 | 7.60 | 8.47 | |||||
| P/S TTM | 2.03 | 2.43 | 2.54 | 2.81 | 3.59 | 3.25 | 3.77 | 3.48 | 4.19 | 3.85 | 3.48 | 3.69 | |||||
| Market Cap | 5.16B | 6.14B | 6.42B | 7.07B | 8.94B | 7.90B | 8.96B | 8.12B | 9.61B | 8.71B | 7.75B | 8.06B | |||||
| Enterprise Value | 5.23B | 6.07B | 6.29B | 6.82B | 8.77B | 7.72B | 8.72B | 7.90B | 9.30B | 8.45B | 7.58B | 7.90B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 377.12M | 325.48M | 360.44M | 371.39M | 315.04M | 367.97M | 312.60M | 252.90M | 302.36M | 273.45M | 258.60M | 279.89M | |||||
| Net Debt | 74.34M | -74.52M | -129.75M | -249.90M | -173.88M | -178.35M | -238.45M | -222.90M | -313.35M | -263.96M | -173.15M | -159.92M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
CHEMED CORP (CHE) — SEC Financial Statements & Analysis
CHEMED CORP (CHE) is a services-home health care services company, incorporated in DE. CHEMED CORP trades on NYSE as: CHE. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), CHEMED CORP reported a 2.07% year-over-year revenue growth, a Gross Profit Margin of 32.38% (TTM), a Debt-to-Equity ratio of 0.81x, a Price-to-Sales (P/S) ratio of 2.03x (TTM), a Price-to-Book (P/B) ratio of 6.08 (TTM), at a market cap of $5.16B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 2.07%
- Gross Profit Margin TTM
- 32.38%
- Debt To Equity
- 0.81x
- P/S TTM
- 2.03x
- P/B TTM
- 6.08
- Market Cap
- $5.16B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CHEMED CORP in?
CHEMED CORP (CHE) operates in the Services-Home Health Care Services industry.
What is CHE's market cap?
CHEMED CORP (CHE) has a market capitalization of $5.16B as of 2026-03-31.
What is CHE's P/E ratio?
CHEMED CORP (CHE)'s trailing twelve month P/E ratio is 19.86x as of 2026-03-31.
What exchange does CHE trade on?
CHEMED CORP (CHE) trades on the NYSE.
Where is CHEMED CORP incorporated?
CHEMED CORP is incorporated in DE.